385114002 | View Concept | SNOMED CT

Component help	Language Code help	Type	Term help	Case Significance help	Acceptability	Active
2621574015 - Patch (en) View
2621574015	en	Synonym (core metadata concept)	Patch	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Acceptable	False
3634739013 - Prolonged-release transdermal patch (en) View
3634739013	en	Synonym (core metadata concept)	Prolonged-release transdermal patch	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True
3634738017 - Prolonged-release transdermal patch (dose form) (en) View
3634738017	en	Fully specified name (core metadata concept)	Prolonged-release transdermal patch (dose form)	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	True
1479376011 - Transdermal patch (en) View
1479376011	en	Synonym (core metadata concept)	Transdermal patch	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	False
2660372013 - Transdermal patch (qualifier value) (en) View
2660372013	en	Fully specified name (core metadata concept)	Transdermal patch (qualifier value)	900000000000448009 \|Entire term case insensitive (core metadata concept)\|	Preferred	False
1459292019 - Transdermal patch (product) (en) View
1459292019	en	Fully specified name (core metadata concept)	Transdermal patch (product)	900000000000020002 \|Only initial character case insensitive (core metadata concept)\|	Preferred	False

Type help	Destination help	Relationship group help	Characteristic type help	Active
Relationship (2008696021) - 385114002 -> 385275000 (116680003) View
116680003 \|Is a (attribute)\|	385275000 \|Cutaneous and/or transdermal dosage form (product)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (2946487026) - 385114002 -> 36875001 (116680003) View
116680003 \|Is a (attribute)\|	36875001 \|Drug patch (qualifier value)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (7545176027) - 385114002 -> 738987007 (736474004) View
736474004 \|Has dose form intended site (attribute)\|	738987007 \|Transdermal (intended site)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7599375025) - 385114002 -> 761845009 (116680003) View
116680003 \|Is a (attribute)\|	761845009 \|Transdermal dose form (dose form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7652641025) - 385114002 -> 738991002 (736472000) View
736472000 \|Has dose form administration method (attribute)\|	738991002 \|Apply (administration method)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7652642021) - 385114002 -> 761954006 (736473005) View
736473005 \|Has dose form transformation (attribute)\|	761954006 \|No transformation (transformation)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7652643027) - 385114002 -> 736847009 (736475003) View
736475003 \|Has dose form release characteristic (attribute)\|	736847009 \|Prolonged-release (release characteristic)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7652644022) - 385114002 -> 739003001 (736476002) View
736476002 \|Has basic dose form (attribute)\|	739003001 \|Patch (basic dose form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active
736847009 View
736847009	Prolonged-release (release characteristic)	Prolonged-release	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
738987007 View
738987007	Transdermal (intended site)	Transdermal	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
738991002 View
738991002	Apply (administration method)	Apply	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
739003001 View
739003001	Patch (basic dose form)	Patch	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True
761845009 View
761845009	Transdermal dose form (dose form)	Transdermal dose form	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
761954006 View
761954006	No transformation (transformation)	No transformation	900000000000074008 \|Necessary but not sufficient concept definition status (core metadata concept)\|	True

Fully Specified Name (FSN)	Shortest Term	Definition Status help	Active
1371025002 View
1371025002	Product containing precisely testosterone 2.5 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Testosterone 2.5 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371026001 View
1371026001	Product containing precisely testosterone 5 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Testosterone 5 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371027005 View
1371027005	Product containing precisely testosterone 6 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Testosterone 6 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371030003 View
1371030003	Product containing precisely selegiline 6 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Selegiline 6 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371031004 View
1371031004	Product containing precisely selegiline 9 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Selegiline 9 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371032006 View
1371032006	Product containing precisely selegiline 12 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Selegiline 12 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371033001 View
1371033001	Product containing precisely scopolamine 1 milligram/72 hour prolonged-release transdermal patch (clinical drug)	Scopolamine 1 mg/72 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371034007 View
1371034007	Product containing precisely rotigotine 6 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Rotigotine 6 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371035008 View
1371035008	Product containing precisely rotigotine 3 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Rotigotine 3 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371036009 View
1371036009	Product containing precisely rotigotine 4 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Rotigotine 4 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371037000 View
1371037000	Product containing precisely rotigotine 2 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Rotigotine 2 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371038005 View
1371038005	Product containing precisely rotigotine 1 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Rotigotine 1 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371039002 View
1371039002	Product containing precisely granisetron 3.1 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Granisetron 3.1 mg/ 24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371040000 View
1371040000	Product containing precisely nicotine 25 milligram/16 hour prolonged-release transdermal patch (clinical drug)	Nicotine 25 mg/16 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371042008 View
1371042008	Product containing precisely nicotine 7 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Nicotine 7 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371043003 View
1371043003	Product containing precisely nicotine 14 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Nicotine 14 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371044009 View
1371044009	Product containing precisely oxybutynin 3.9 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Oxybutynin 3.9 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371092009 View
1371092009	Product containing precisely rivastigmine 4.6 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Rivastigmine 4.6 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371093004 View
1371093004	Product containing precisely rivastigmine 9.5 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Rivastigmine 9.5 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371094005 View
1371094005	Product containing precisely nicotine 15 milligram/16 hour prolonged-release transdermal patch (clinical drug)	Nicotine 15 mg/16 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371095006 View
1371095006	Product containing precisely nicotine 10 milligram/16 hour prolonged-release transdermal patch (clinical drug)	Nicotine 10 mg/16 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371096007 View
1371096007	Product containing precisely nicotine 21 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Nicotine 21 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371117001 View
1371117001	Product containing precisely glyceryl trinitrate 10 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Nitroglycerin 10 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371118006 View
1371118006	Product containing precisely glyceryl trinitrate 5 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Nitroglycerin 5 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371119003 View
1371119003	Product containing precisely glyceryl trinitrate 15 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Nitroglycerin 15 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371251005 View
1371251005	Product containing precisely estradiol 25 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 25 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371252003 View
1371252003	Product containing precisely estradiol 37.5 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 37.5 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371253008 View
1371253008	Product containing precisely estradiol 50 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 50 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371256000 View
1371256000	Product containing precisely estradiol 60 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 60 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371258004 View
1371258004	Product containing precisely estradiol 14 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 14 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371259007 View
1371259007	Product containing precisely estradiol 100 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 100 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371260002 View
1371260002	Product containing precisely estradiol 80 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 80 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371261003 View
1371261003	Product containing precisely estradiol 75 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 75 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371262005 View
1371262005	Product containing precisely estradiol 40 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 40 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371268009 View
1371268009	Product containing precisely estradiol 50 microgram/24 hour and norethisterone acetate 170 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 50 microgram/24 hour and norethindrone acetate 170 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371269001 View
1371269001	Product containing precisely estradiol 50 microgram/24 hour and norethisterone acetate 250 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 50 microgram/24 hour and norethindrone acetate 250 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371270000 View
1371270000	Product containing precisely estradiol 50 microgram/24 hour and norethisterone acetate 140 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 50 microgram/24 hour and norethindrone acetate 140 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371272008 View
1371272008	Product containing precisely ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Ethinylestradiol 35 microgram/24 hour and norelgestromin 150 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371334001 View
1371334001	Product containing precisely estradiol 45 microgram/24 hour and levonorgestrel 15 microgram/24 hour prolonged-release transdermal patch (clinical drug)	Estradiol 45 microgram/24 hour and levonorgestrel 15 microgram/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371749007 View
1371749007	Product containing precisely glyceryl trinitrate 20 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Nitroglycerin 20 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371776007 View
1371776007	Product containing precisely nicotine 5 milligram/16 hour prolonged-release transdermal patch (clinical drug)	Nicotine 5 mg/16 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1371800005 View
1371800005	Product containing precisely glyceryl trinitrate 7.5 milligram/24 hour prolonged-release transdermal patch (clinical drug)	Nitroglycerin 7.5 mg/24 hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1236886008 View
1236886008	Product containing precisely buprenorphine 15 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Buprenorphine 15 microgram/hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
1231483005 View
1231483005	Product containing precisely buprenorphine 5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Buprenorphine 5 microgram/hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
417634007 View
417634007	Fentanyl 12micrograms/hour patch (product)	Fentanyl 12micrograms/hour patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
447180001 View
447180001	Buprenorphine 10microgram/hour transdermal patch (product)	Buprenorphine 10microgram/hour transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
447181002 View
447181002	Buprenorphine 20microgram/hour transdermal patch (product)	Buprenorphine 20microgram/hour transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
769510009 View
769510009	Product containing precisely fentanyl 25 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Fentanyl 25 microgram/hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
769511008 View
769511008	Product containing precisely buprenorphine 35 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Buprenorphine 35 microgram/hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
769512001 View
769512001	Product containing precisely fentanyl 50 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Fentanyl 50 microgram/hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
769513006 View
769513006	Product containing precisely buprenorphine 52.5 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Buprenorphine 52.5 microgram/hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
769514000 View
769514000	Product containing precisely buprenorphine 70 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Buprenorphine 70 microgram/hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
769515004 View
769515004	Product containing precisely fentanyl 75 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Fentanyl 75 microgram/hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True
769517007 View
769517007	Product containing precisely fentanyl 100 microgram/1 hour prolonged-release transdermal patch (clinical drug)	Fentanyl 100 microgram/hour prolonged-release transdermal patch	900000000000073002 \|Sufficiently defined by necessary conditions definition status (core metadata concept)\|	True

Reference Set help	Map Target help	Map Rule help	Map Advice help	Correlation help	Map Category help

Type help	Destination help	Relationship group help	Characteristic type help	Active
Relationship (2008696021) - 385114002 -> 385275000 (116680003) View
116680003 \|Is a (attribute)\|	385275000 \|Cutaneous and/or transdermal dosage form (product)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (2946487026) - 385114002 -> 36875001 (116680003) View
116680003 \|Is a (attribute)\|	36875001 \|Drug patch (qualifier value)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	False
Relationship (7545176027) - 385114002 -> 738987007 (736474004) View
736474004 \|Has dose form intended site (attribute)\|	738987007 \|Transdermal (intended site)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7599375025) - 385114002 -> 761845009 (116680003) View
116680003 \|Is a (attribute)\|	761845009 \|Transdermal dose form (dose form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7652641025) - 385114002 -> 738991002 (736472000) View
736472000 \|Has dose form administration method (attribute)\|	738991002 \|Apply (administration method)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7652642021) - 385114002 -> 761954006 (736473005) View
736473005 \|Has dose form transformation (attribute)\|	761954006 \|No transformation (transformation)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7652643027) - 385114002 -> 736847009 (736475003) View
736475003 \|Has dose form release characteristic (attribute)\|	736847009 \|Prolonged-release (release characteristic)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True
Relationship (7652644022) - 385114002 -> 739003001 (736476002) View
736476002 \|Has basic dose form (attribute)\|	739003001 \|Patch (basic dose form)\|	0	900000000000011006 \|Inferred relationship (core metadata concept)\|	True

Terminology chevron_right Concepts chevron_right 385114002

Recent searches

Terminology chevron_right Concepts chevron_right 385114002

Descriptions

Relationships

Parent Concepts

Children Concepts

Extended Maps

Recent searches